Illumina stock downgraded
3 Jan 2020 Illumina stock downgraded. to 'In-Line' by Evercore ISI. genomeweb. Investment banking firm Evercore ISI has downgraded shares of Illumina 18 Feb 2020 Illumina, Inc. of upgrading estimates High Value Number of unchanged estimates Mean Value Number of downgrading estimates Low Value Illumina, Inc. (ILMN) Stock. $233.33 10.05 (4.50%) Upgrades and Downgrades: Mastercard and Illumina. Today's upgrades and downgrades include: Mastercard (MA.N) at Cowen & Co., and Illumina (ILMN. Illumina, Inc. develops, manufactures and markets integrated systems for the analysis of genetic variation and function. The company provides sequencing and Illumina: PharmiWeb.com — DNA sequencing Market Expected Growing at CAGR Illumina: TechCrunch — Mammoth Biosciences aims to be Illumina for the Illumina: Benzinga — BofA Double Downgrades Illumina After Thursday's ' Big Miss' Illumina: The Street — Illumina, One of My Short Stock Candidates, Shows Illumina's stock tumbles after revenue warning prompts double downgrade at BofA Merrill Lynch That downgrade follows the company's disclosing late Thursday that it now expects second-quarter
Shares of Illumina, Inc. (NASDAQ:ILMN) gapped down prior to trading on Friday after BidaskClub downgraded the stock from a strong-buy rating to a buy rating. The stock had previously closed at $294.50, but opened at $296.00. Illumina shares last traded at $289.86, with a volume of 786,973 shares. A number of other equities analysts have […]
NEW YORK – Investment banking firm Evercore ISI has downgraded shares of Illumina to an In Line rating, with a price target of $340. "We are downgrading Illumina to In Line as we see risks and upside surprises as being fairly balanced at current levels," analyst Vijay Kumar wrote in a research note. Illumina, Inc. (NASDAQ:ILMN)’s stock price gapped down before the market opened on Friday after BidaskClub downgraded the stock from a strong-buy rating to a buy rating. The stock had previously closed at $294.50, but opened at $296.00. Illumina shares last traded at $289.86, with a volume of 786,973 shares traded. Several other analysts have also […] Gene-sequencing giant Illumina was sliding on the stock market Tuesday after Morgan Stanley downgraded it based on negative trends in key markets.. Analyst Steve Beuchaw cut his rating to Illumina, Inc. Common Stock (ILMN) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. View Illumina, Inc. ILMN investment & stock information. Get the latest Illumina, Inc. ILMN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ILMN stock was sold by a variety of institutional investors in the last quarter, including Jennison Associates LLC, First Hawaiian Bank, Fred Alger Management LLC, Jackson Square Partners LLC, First Trust Advisors LP, Sands Capital Management LLC, Janus Henderson Group PLC, and FIL Ltd. Company insiders that have sold Illumina company stock in
Illumina (NASDAQ:ILMN) was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating in a research report issued on Friday, ValuEngine reports. ILMN has been the topic of several other reports.
NEW YORK – Investment banking firm Evercore ISI has downgraded shares of Illumina to an In Line rating, with a price target of $340. "We are downgrading Illumina to In Line as we see risks and upside surprises as being fairly balanced at current levels," analyst Vijay Kumar wrote in a research note. Illumina, Inc. (NASDAQ:ILMN)’s stock price gapped down before the market opened on Friday after BidaskClub downgraded the stock from a strong-buy rating to a buy rating. The stock had previously closed at $294.50, but opened at $296.00. Illumina shares last traded at $289.86, with a volume of 786,973 shares traded. Several other analysts have also […] Gene-sequencing giant Illumina was sliding on the stock market Tuesday after Morgan Stanley downgraded it based on negative trends in key markets.. Analyst Steve Beuchaw cut his rating to Illumina, Inc. Common Stock (ILMN) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.
Shares of gene-sequencing giant Illumina tumbled to a nearly one-year low Thursday after the stock was downgraded and a competing product arrived earlier than expected. Leerink analyst Dan Leonard
Illumina, Inc. (ILMN) Stock. $233.33 10.05 (4.50%)
Real time Illumina (ILMN) stock price quote, stock graph, news & analysis.
Shares of Illumina, Inc. (NASDAQ:ILMN) gapped down prior to trading on Friday after BidaskClub downgraded the stock from a strong-buy rating to a buy rating. The stock had previously closed at $294.50, but opened at $296.00. Illumina shares last traded at $289.86, with a volume of 786,973 shares. A number of other equities analysts have […] NEW YORK – Investment banking firm Evercore ISI has downgraded shares of Illumina to an In Line rating, with a price target of $340. "We are downgrading Illumina to In Line as we see risks and upside surprises as being fairly balanced at current levels," analyst Vijay Kumar wrote in a research note. Illumina, Inc. (NASDAQ:ILMN)’s stock price gapped down before the market opened on Friday after BidaskClub downgraded the stock from a strong-buy rating to a buy rating. The stock had previously closed at $294.50, but opened at $296.00. Illumina shares last traded at $289.86, with a volume of 786,973 shares traded. Several other analysts have also […] Gene-sequencing giant Illumina was sliding on the stock market Tuesday after Morgan Stanley downgraded it based on negative trends in key markets.. Analyst Steve Beuchaw cut his rating to Illumina, Inc. Common Stock (ILMN) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.
Shares of Illumina, Inc. (NASDAQ:ILMN) gapped down prior to trading on Friday after BidaskClub downgraded the stock from a strong-buy rating to a buy rating. The stock had previously closed at $294.50, but opened at $296.00. Illumina shares last traded at $289.86, with a volume of 786,973 shares. A number of other equities analysts have […] NEW YORK – Investment banking firm Evercore ISI has downgraded shares of Illumina to an In Line rating, with a price target of $340. "We are downgrading Illumina to In Line as we see risks and upside surprises as being fairly balanced at current levels," analyst Vijay Kumar wrote in a research note.